AC
ALT icon

AXQ Capital’s Altimmune ALT Stock Holding History

AXQ Capital’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$147K Buy
47,752
+22,051
+86% +$93.6K 0.02% 814
2025
Q4 		$92.8K Buy
25,701
+5,266
+26% +$23K 0.02% 664
2025
Q3 		$77K Sell
20,435
-20,847
-50% -$80.5K 0.03% 529
2025
Q2 		$160K Buy
+41,282
New +$223K 0.05% 482
2025
Q1 		– Sell
-12,388
Closed -$89.3K – 487
2024
Q4 		$89.3K Sell
12,388
-11,107
-47% -$84.9K 0.04% 382
2024
Q3 		$144K Buy
+23,495
New +$159K 0.04% 388

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AXQ Capital's ALT Position: Q1 2026 in Review

AXQ Capital increased its Altimmune (ALT) stake by 86% in Q1 2026, buying an estimated $93.6K and bringing the position to 47,752 shares worth $147K. The position accounts for 0.02% of the portfolio, ranked #814.

AXQ Capital first reported a position in ALT in Q3 2024 and has held it in 6 quarters since. The position peaked at $160K in Q2 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • AXQ Capital held 47,752 shares of Altimmune worth $147K as of Q1 2026.
  • AXQ Capital bought 22,051 Altimmune shares in Q1 2026, an estimated $93.6K.
  • Altimmune made up 0.02% of AXQ Capital's portfolio in Q1 2026, its #814 holding.
  • AXQ Capital first reported a position in Altimmune in Q3 2024 and has held it in 6 quarters since.
  • AXQ Capital's Altimmune position peaked at $160K in Q2 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.